Sponsor Us

Magnify strives to enhance the vibrant culture of entrepreneurship at UCLA and the broader Los Angeles region.

Featuring flexible co-working laboratory and office spaces, Magnify was built with one goal in mind: to help startups succeed by vastly accelerating their access to facilities while increasing their capital efficiency and market opportunities.

Building upon the university’s Michelson Center for Convergent Bioscience Initiative, the Bridge Institute unites artists, engineers, scientists and physicians from USC, bridging the molecules of life to improve the human condition.

​

Imagine a world where scientific data is released from the confines of its originating discipline, allowing us to better understand, integrate and advance knowledge.

Founded in 1997, we are proud to be a member of The Claremont Colleges. With an entrepreneurial approach and industry connections, KGI provides pathways for students to become leaders in healthcare and the applied life sciences.

LA BioSpace is leading Cal State LA’s mission to promote a thriving bioscience ecosystem in the heart of Los Angeles. They provide emerging entrepreneurs with flexible facilities, resources, training and knowledge to launch startup ventures and spur regional economic development. As its programming component, LA BioStart is a comprehensive 5-week mentoring program that grows high-level biotech leaders. It will offer cohort 8 in the summer of 2025 (at no cost to eligible participants).

Teknova is a leading reagents manufacturer with nearly 30 years of expertise, serving over 3,000 life sciences customers with high-quality catalog and custom solutions. With ISO 13485–certified facilities, Teknova offers more than 1,400 ready-to-ship products and delivers RUO, RUO+, and GMP-grade custom formulations with fast turnaround and commercial-scale capacity. From its Hollister, California headquarters, Teknova’s team supports the discovery and development of next-generation therapies and diagnostics.

Amgen is a global biotech leader with over 40 years of innovation, focused on discovering and delivering medicines that improve and extend lives. By combining biology, technology, and human genetic data, Amgen tackles serious illnesses—from cancer to rare diseases—with a robust pipeline and proven impact. As one of the 30 companies in the Dow Jones Industrial Average and a proud member of the Nasdaq-100 Index, Amgen continues to set the standard in life science innovation and impact.